The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.
Saved in:
| Title: | The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma. |
|---|---|
| Authors: | Azfar M; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium., Gao W; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Van den Haute C; Group for Neurobiology and Gene Therapy, KU Leuven, Belgium.; Leuven Viral Vector Core, KU Leuven, Belgium., Xiao L; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Karsa M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Pandher R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Karsa A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia., Spurling D; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia., Ronca E; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia., Bongers A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia., Guo X; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia., Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Fayt Y; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium., Schoofs A; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium., Burns MR; Aminex Therapeutics, Aminex Therapeutics Inc., Kirkland, WA, USA., Verhelst SHL; Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven, Belgium., Norris MD; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia.; UNSW Centre for Childhood Cancer Research, UNSW Sydney, Australia., Haber M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia., Vangheluwe P; Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Belgium., Somers K; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Australia. |
| Source: | Molecular oncology [Mol Oncol] 2025 Mar; Vol. 19 (3), pp. 913-936. Date of Electronic Publication: 2025 Feb 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.13789 |
